Cyclo-Oxygenase-2 and its Inhibition in Cancer
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 67 (6) , 821-845
- https://doi.org/10.2165/00003495-200767060-00001
Abstract
No abstract availableKeywords
This publication has 198 references indexed in Scilit:
- Celecoxib for the Prevention of Colorectal Adenomatous PolypsNew England Journal of Medicine, 2006
- Celecoxib for the Prevention of Sporadic Colorectal AdenomasNew England Journal of Medicine, 2006
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Overexpression of Cyclooxygenase-2 in Nasopharyngeal Carcinoma and Association With Epidermal Growth Factor Receptor ExpressionJAMA Otolaryngology–Head & Neck Surgery, 2005
- Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast CancerJournal of Biological Chemistry, 2002
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cellsEuropean Journal Of Cancer, 2000
- Reciprocal paracrine interactions between tumour cells and endothelial cells: the ‘angiogenesis progression’ hypothesisEuropean Journal Of Cancer, 1996
- Prostaglandin modulation of development of cell-mediated immunity in cultureNature, 1980